Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety and efficacy of CTP-499 in patients with type 2 diabetic nephropathy (type 2 diabetes mellitus with chronic kidney disease) has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• CTP-499 (CTP-499)

Snippet

Sponsor: Concert Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus, Chronic Kidney Disease | Phase 2 | Status: COMPLETED